Tumor Suppressive MicroRNA-218 Inhibits Cancer Cell Migration and Invasion Through Targeting Laminin-332 in Head and Neck Squamous Cell Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2012 Nov 20

PMID 23159910

Citations 72

Authors

Takashi Kinoshita

Toyoyuki Hanazawa

Nijiro Nohata

Naoko Kikkawa

Hideki Enokida

Hirofumi Yoshino

Takeshi Yamasaki

Hideo Hidaka

Masayuki Nakagawa

Yoshitaka Okamoto

Naohiko Seki

Affiliations

Soon will be listed here.

Abstract

Recent our microRNA (miRNA) expression signature revealed that expression of microRNA-218 (miR-218) was reduced in cancer tissues, suggesting a candidate of tumor suppressor in head and neck squamous cell carcinoma (HNSCC). The aim of this study was to investigate the functional significance of miR-218 and its mediated moleculer pathways in HNSCC. Restoration of miR-218 in cancer cells led to significant inhibition of cell migration and invasion activities in HNSCC cell lines (FaDu and SAS). Genome-wide gene expression analysis of miR-218 transfectants and in silico database analysis showed that focal adhesion pathway was a promising candidate of miR-218 target pathways. The laminins are an important and biologically active part of the basal lamina, the function of that are various such as influencing cell differentiation, migration and adhesion as well as proliferation and cell survival. Interestingly, all components of laminin-332 (LAMA3, LAMB3 and LAMC2) are listed on the candidate genes in focal adhesion pathway. Furthermore, we focused on LAMB3 which has a miR-218 target site and gene expression studies and luciferase reporter assays showed that LAMB3 was directly regulated by miR-218. Silencing study of LAMB3 demonstrated significant inhibition of cell migration and invasion. In clinical specimens with HNSCC, the expression levels of laminin-332 were significantly upregulated in cancer tissues compared to adjacent non-cancerous tissues. Our analysis data showed that tumor suppressive miR-218 contributes to cancer cell migration and invasion through regulating focal adhesion pathway, especially laminin-332. Tumor suppressive miRNA-mediated novel cancer pathways provide new insights into the potential mechanisms of HNSCC oncogenesis.

Citing Articles

Research on the expression of Mir-218-2 in the serum of patients with papillary thyroid cancer and its clinical significance.

He H, Hao D, Tian L, Zhu C, Guo L, Zhang K Eur J Transl Myol. 2024; 34(3).

PMID: 39221591 PMC: 11487670. DOI: 10.4081/ejtm.2024.12678.

Matricellular proteins: Potential biomarkers in head and neck cancer.

Wang Y, Liu X, Wang X, Lu J, Tian Y, Liu Q J Cell Commun Signal. 2024; 18(2):e12027.

PMID: 38946720 PMC: 11208127. DOI: 10.1002/ccs3.12027.

Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review.

Verro B, Saraniti C, Carlisi D, Chiesa-Estomba C, Maniaci A, Lechien J Cancers (Basel). 2023; 15(20).

PMID: 37894464 PMC: 10604942. DOI: 10.3390/cancers15205096.

MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma.

Nakashiro K, Tokuzen N, Saika M, Shirai H, Kuribayashi N, Goda H Cancers (Basel). 2023; 15(16).

PMID: 37627167 PMC: 10452613. DOI: 10.3390/cancers15164138.

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer.

Wang Y, Li G, Wang Z, Wang W, Wang X, Luo X Front Mol Biosci. 2023; 10:1157970.

PMID: 37577750 PMC: 10415034. DOI: 10.3389/fmolb.2023.1157970.

References

Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A . GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 2012; 40(Web Server issue):W478-83. PMC: 3394297. DOI: 10.1093/nar/gks402. View

Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K . The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer. 2011; 104(5):808-18. PMC: 3048214. DOI: 10.1038/bjc.2011.23. View

Kinoshita T, Nohata N, Watanabe-Takano H, Yoshino H, Hidaka H, Fujimura L . Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. Int J Oncol. 2012; 40(6):1770-8. DOI: 10.3892/ijo.2012.1390. View

Davidson M, Larsen J, Yang I, Hayward N, Clarke B, Duhig E . MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One. 2010; 5(9):e12560. PMC: 2933228. DOI: 10.1371/journal.pone.0012560. View

Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y . miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2011; 127(12):2804-14. DOI: 10.1002/ijc.25284. View

Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H . miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol. 2011; 39(1):13-21. DOI: 10.3892/ijo.2011.1012. View

Mutallip M, Nohata N, Hanazawa T, Kikkawa N, Horiguchi S, Fujimura L . Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med. 2010; 27(3):345-52. DOI: 10.3892/ijmm.2010.589. View

Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H . miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget. 2011; 2(1-2):29-42. PMC: 3248152. DOI: 10.18632/oncotarget.213. View

Tran N, OBrien C, Clark J, Rose B . Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck. 2010; 32(8):1099-111. DOI: 10.1002/hed.21356. View

10.

Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K . Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol. 2010; 30(4):434-43. DOI: 10.1016/j.urolonc.2010.05.008. View

11.

Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S . Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet. 2011; 57(1):38-45. DOI: 10.1038/jhg.2011.126. View

12.

Murai S, Umemiya T, Seiki M, Harigaya K . Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression. Virchows Arch. 2004; 445(3):271-8. DOI: 10.1007/s00428-004-1029-x. View

13.

Mizejewski G . Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999; 222(2):124-38. DOI: 10.1177/153537029922200203. View

14.

Katayama M, Sekiguchi K . Laminin-5 in epithelial tumour invasion. J Mol Histol. 2004; 35(3):277-86. DOI: 10.1023/b:hijo.0000032359.35698.fe. View

15.

Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K . Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009; 125(2):345-52. DOI: 10.1002/ijc.24390. View

16.

Carter W, Ryan M, Gahr P . Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell. 1991; 65(4):599-610. DOI: 10.1016/0092-8674(91)90092-d. View

17.

Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Fujimura L, Chiyomaru T . Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer. 2011; 105(6):833-41. PMC: 3171017. DOI: 10.1038/bjc.2011.311. View

18.

Davis-Dusenbery B, Hata A . MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways. Genes Cancer. 2011; 1(11):1100-14. PMC: 3083114. DOI: 10.1177/1947601910396213. View

19.

Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S . MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010; 6(3):e1000879. PMC: 2837402. DOI: 10.1371/journal.pgen.1000879. View

20.

Leemans C, Braakhuis B, Brakenhoff R . The molecular biology of head and neck cancer. Nat Rev Cancer. 2010; 11(1):9-22. DOI: 10.1038/nrc2982. View